Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 7, 2015; 21(25): 7851-7859
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7851
Table 1 Results of the preliminary study to establish criteria for the outcomes assessed in the blinded trial
Spectral lineNormalmucosaHyperplasticpolypsLow-grade1High-grade2Adeno
adenomaadenomacarcinomas
(n= 47)(n= 29)(n= 16)(n= 4)(n= 10)
465 MHz0025-3030-3560-70
930 MHz0> 40> 40> 4035-45
1395 MHz000-1065-7035-45
Table 2 Sensitivity, specificity, positive and negative predictive value of the TRIMprob analysis compared to the gold standard (colonoscopy and histology) in detecting biological anomalies of colonic mucosa for the whole cohort, and for the non-inflammatory bowel disease cohort
HistologyColonoscopy(No. of positive cases/total No. of cases)TRIMProb(No. of TP, FP, FN, TN)Sensitivity, % (95%CI)Specificity, % (95%CI)Positive predictive value, % (95%CI)Negative predictive value, % (95%CI)
All cases156/30515412213798.791.992.898.6
(IBD + Non IBD)(95.4-99.6)(86.4-95.3)(87.8-95.8)(94.9-99.6)
Non IBD cases149/2811475212798.796.296.798.4
(95.2-99.6)(91.4-98.4)(92.5-98.6)(94.5-99.6)
Hyperplastic173/281714220497.398.194.799
(90.5-99.2)(95.2-99.2)(87.0-97.9)(96.5-99.7)
Adenomas247/281404723085.198.390.997
(72.3-92.6)(95.7-99.3)(78.8-96.4)(94.0-98.6)
Advanced adenomas317/281141326382.499.693.398.9
(58.9-93.8)(97.9-99.9)(70.2-98.8)(96.7-99.6)
Cancer12/2811200269100100100100
(75.7-100.0)(98.5-100.0)(75.7-100.0)(98.6-100.0)
Table 3 Two hundred eighty-one non-inflammatory bowel disease subjects
281 non-IBD patientsNormalHyperplasiaLGDHGDCancerTotal
Colonoscopy
Normal1272000129
Hyperplasia07352080
LGD40401045
TRIM
HGD10014015
Cancer00001212
Total13275451712281